News Coverage 10.17.19 By: Mark Terry Share on Twitter Share on Facebook Share on LinkedIn ArsenalBio Launches with $28 Million Series A to Develop Next-Generation Immunotherapies Related Announcement, Patient Story Living Proof: Cancer Vaccine Recipients Bring Their Sto Research Update Cancer Vaccines: A New Era in Cancer Treatment Announcement, Press Release Dr. Sager Named Recipient of PICI’s Inaugural YIA Award